Skip to main content
. 2022 Apr 30;34(2):71–82. doi: 10.21147/j.issn.1000-9604.2022.02.02

Table 2. Cox regression for training cohort.

Variables Univariate analysis Multivariable analysis
HR (95% CI) P HR (95% CI) P
KPS, Karnofsky performance status; LN, lymph node; NLR, neutrophil to lymphocyte ratio; MPV, mean platelet volume; cTNM, clinical TNM stage; pTNM, pathological TNM stage; HR, hazard ratio; 95% CI, 95% confidence interval.
Age (year)
 <65 1 (reference)
 ≥65 1.11 (0.89−1.40) 0.352
Gender
 Male 1 (reference) 1 (reference)
 Female 0.54 (0.39−0.75) <0.001 0.61 (0.44−0.84) 0.003
KPS
 90−100 1 (reference)
 70−80 1.00 (0.81−1.23) 0.992
Tumor location
 Upper 1 (reference)
 Middle 0.95 (0.75−1.20) 0.682
 Lower 0.92 (0.69−1.23) 0.576
Differentiation
 G1 1 (reference)
 G2 1.14 (0.85−1.53) 0.380
 G3 1.24 (0.93−1.65) 0.141
Surgical margin
 R0 1 (reference)
 R1/2 1.56 (1.06−2.30) 0.023
Vascular invasion
 No 1 (reference)
 Yes 1.68 (1.32−2.14) <0.001
Neural invasion
 No 1 (reference)
 Yes 1.56 (1.21−2.01) <0.001
Resected LN number
 <20 1 (reference)
 ≥20 1.03 (0.84−1.27) 0.749
Na (mmol/L)
 <139 1 (reference) 1 (reference)
 ≥139 0.78 (0.61−0.98) 0.036 0.79 (0.62−0.99) 0.045
NLR
 <3.5 1 (reference)
 ≥3.5 1.01 (0.80−1.28) 0.904
MPV (fL)
 <12.7 1 (reference)
 ≥12.7 0.81 (0.64−1.03) 0.084
cTNM
 I 1 (reference)
 II 3.58 (0.88−14.51) 0.074
 III 3.46 (0.86−13.98) 0.082
 IV 4.72 (1.17−19.07) 0.029
pTNM (8th)
 I 1 (reference) 1 (reference)
 II 1.98 (1.02−3.81) 0.042 1.48 (0.76−2.87) 0.245
 III 4.91 (2.60−9.27) <0.001 3.36 (1.76−6.41) <0.001
 IV 8.86 (4.58−17.14) <0.001 4.86 (2.44−9.66) <0.001
Radiomics index (continuous) 3.54 (2.72−4.61) <0.001 2.12 (1.59−2.83) <0.001